ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för nelfinavir. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

13 träffar

Bibliografisk träff 2014-06-18

Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial.

Hoover AC, Milhem MM, Anderson CM, Sun W, Smith BJ, Hoffman HT, Buatti JM.

Head Neck · clinical trial, phase ii; clinical trial; research-article; journal article · DOI 10.1002/hed.23664

Bibliografisk träff 2014-04-09

HIV-1 protease-substrate coevolution in nelfinavir resistance.

Kolli M, Ozen A, Kurt-Yilmaz N, Schiffer CA.

J Virol · research-article; journal article; research support, n.i.h., extramural · DOI 10.1128/jvi.00266-14

Bibliografisk träff 2014-02-26

Nelfinavir inhibits maturation and export of herpes simplex virus 1.

Kalu NN, Desai PJ, Shirley CM, Gibson W, Dennis PA, Ambinder RF.

J Virol · research-article; journal article; research support, n.i.h., extramural · DOI 10.1128/jvi.03790-13

Bibliografisk träff 2014-01-31

The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cells.

Kushchayeva Y, Jensen K, Recupero A, Costello J, Patel A, Klubo-Gwiezdzinska J, Boyle L, Burman K, Vasko V.

J Clin Endocrinol Metab · journal article · DOI 10.1210/jc.2013-3369

Bibliografisk träff 2014-01-31

New insights into the in silico prediction of HIV protease resistance to nelfinavir.

Antunes DA, Rigo MM, Sinigaglia M, de Medeiros RM, Junqueira DM, Almeida SE, Vieira GF.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0087520

Bibliografisk träff 2013-12-25

Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations.

Kraus M, Müller-Ide H, Rückrich T, Bader J, Overkleeft H, Driessen C.

Leuk Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.leukres.2013.12.017

Bibliografisk träff 2013-11-06

A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme.

Alonso-Basanta M, Fang P, Maity A, Hahn SM, Lustig RA, Dorsey JF.

J Neurooncol · research support, non-u.s. gov't; research-article; clinical trial, phase i; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.1007/s11060-013-1303-3

Bibliografisk träff 2013-09-01

Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention.

Gantt S, Casper C, Ambinder RF.

Curr Opin Oncol · research-article; review; journal article; research support, n.i.h., extramural · DOI 10.1097/cco.0b013e328363dfee

Bibliografisk träff 2013-08-01

Indinavir and nelfinavir inhibit proximal insulin receptor signaling and salicylate abrogates inhibition: potential role of the NFkappa B pathway.

Ismail WI, King JA, Anwar K, Pillay TS.

J Cell Biochem · research support, non-u.s. gov't; journal article · DOI 10.1002/jcb.24513

Bibliografisk träff 2013-07-20

Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation.

Brüning A, Rahmeh M, Friese K.

Mol Oncol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1016/j.molonc.2013.07.010

Bibliografisk träff 2013-05-03

Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancer.

Buijsen J, Lammering G, Jansen RL, Beets GL, Wals J, Sosef M, Den Boer MO, Leijtens J, Riedl RG, Theys J, Lambin P.

Radiother Oncol · research support, non-u.s. gov't; clinical trial, phase i; journal article · DOI 10.1016/j.radonc.2013.03.023

Bibliografisk träff 2013-03-01

Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance.

Kraus M, Bader J, Overkleeft H, Driessen C.

Blood Cancer J · research-article; journal article · DOI 10.1038/bcj.2013.2

Bibliografisk träff 2012-10-28

Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients.

Santos LO, Vitório BS, Branquinha MH, Pedroso e Silva CM, Santos AL, d'Avila-Levy CM.

J Antimicrob Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1093/jac/dks410